Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jasper Boeddinghaus MD

Jasper Boeddinghaus MD

Consultant, Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, University of Basel, Basel, Switzerland; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK

Jasper Boeddinghaus is a specialist in internal medicine and cardiology and currently works as a consultant in the Department of Cardiology. After studying human medicine and completing his doctorate in basic cardiology research at the University Medical Center Hamburg-Eppendorf (UKE), he trained as an internist and cardiologist at the University Hospital Basel and the University Heart Center Freiburg-Bad Krozingen.

During a two-year fellowship at the University of Edinburgh and the Royal Infirmary of Edinburgh in Scotland, he specialized in interventional and structural cardiology. His clinical focus is on the interventional treatment of coronary and valvular heart disease with a particular interest in complex coronary interventions.

Scientifically, Dr. Boeddinghaus has been working for years on the optimization of myocardial infarction diagnostics using novel biomarkers as well as artificial intelligence and machine learning. As part of his scientific work at the Cardiovascular Research Institute Basel (CRIB) and the Centre for Cardiovascular Research Edinburgh, Dr. Boeddinghaus is actively involved in a large number of prospective cohorts and randomized studies. He is a Fellow of the European Society of Cardiology and a member of the Biomarker Study Group.

Disclosures

Dr. Boeddinghaus is supported by an Edinburgh Doctoral College Scholarship and received research grants from the University of Basel, the University Hospital of Basel, the Division of Internal Medicine, the Swiss Academy of Medical Sciences, the Gottfried and Julia Bangerter-Rhyner Foundation, the Swiss National Science Foundation, and the “Freie Akademische Gesellschaft Basel”. Dr. Boeddinghaus has received honoraria from Siemens, Roche Diagnostics, Ortho Clinical Diagnostics, Quidel Corporation, and Beckman Coulter, and travel support from Medtronic and Cordis, all outside the submitted presentation.